Diagnosis and classification of myelodysplastic ring sideroblasts

Slides:



Advertisements
Similar presentations
איכילוב 7 46y female WBC=62.000\ul Hb=16.1g% Normal indices
Advertisements

Coding Haematological Malignancies in Cancer Registries part I : Myeloid malignancies Pr Marc Maynadié Registre des Hémopathies Malignes de Côte d'Or Faculté.
NEOPLASTIC DISORDERS OF THE BONE MARROW
Myelodysplastic syndromes Achievements in understanding and treatment prof. dr hab. med. Krzysztof Lewandowski.
Myelodysplastic Syndromes
Myelodysplastic Syndrome
LEUKEMIA—HEMATOLOGY {S1}
Acute Myeloid Leukemia with cytogenetic abnormality
Myelodysplastic Syndrome
Week 12: Myelodysplastic Syndrome
Myelodysplastic syndrome and acute myeloid leukaemia
ACUTE MYELOID LEUKEMIA Irit Avivi
LEUKEMIAS Dr Mehboob Khan Pathologist
Myelodysplastic Syndromes: An Update
Acute Myeloid Leukemias (AML)
Myelodysplastic syndrome overview Razelle Kurzrock Seminars in Haematology, Vol 39, No 3, Suppl 2 (July) 2002, pp
Myelodysplastic syndromes
Myelodysplastic Syndrome
Seyyed Reza Safaee MD Internist- Hematologist&Oncologist Hematology&Oncology& Hematopoietic Stem Cell Transplantation Ward Imam Khomeini General Hospital.
Conflicts of interest: none to declare Monika Klimkowska MD PhD Department of Pathology and Cytology Karolinska University Hospital Stockholm, Sweden.
Myelodysplastic Syndromes: An Update. 80 yo male: OSA, gout, CAD, and prostate cancer who was referred for progressive anemia. Past few months: noticed.
Hematology DR.HASSANALI VAHEDIAN ARDAKANI
M. Sales1, N. Foster1, S. Tauro2, J. Cunningham1, N. Pratt1
Myelodysplastic Syndrome (MDS)
The myelodysplastic syndromes (MDS) Aquired Clonal disease of BM. comprise a heterogeneous group of malignant stem cell disorders characterized by : 1.
MLAB HEMATOLOGY KERI BROPHY-MARTINEZ Myelodysplastic Syndromes.
Morphology Review - ISH Slides - 제 2 차 혈액학 종합학술대회 발표 2000 년 5 월 25 일 -5 월 26 일 COEX 한림의대 조 현 찬.
Overview of Myelodysplastic Syndromes with Focus on Iron Overload Norbert Gattermann, MD, PhD Professor Department of Haematology, Oncology, and Clinical.
CB-1 MDS Classification and Prognosis John M. Bennett, MD University of Rochester Medical Center Hematomorphologist Chair, MDS Foundation.
1 MYELOPROLIFERATIVE SYNDROMES & LEUKEMIA Doç. Dr. Işın Doğan Ekici.
4th Year Medical Student KAU
Myelodysplastic Syndromes Tefferi A, Vardiman JW. New Engl J Med 2009:361(19):
Myelodysplastic disorders
Leukaemias. Leukaemias: Malignant Disease of WBC Forming tissue or other hemopoietic elements: Lymphoblastic (ALL) Lymphoblastic (ALL)Acute Myeloid (AML)
Malignant diseases of the bone marrow Tornóci László Semmelweis University Institute of Pathophysiology.
MLAB Hematology Keri Brophy-Martinez
Acute Leukemia Kristine Krafts, M.D..
Case 255 Elizabeth Courville, MD Robert Hasserjian, MD Massachusetts General Hospital Society for Hematopathology/European Association for Haematopathology.
골수증식 질환 Myeloproliferative disorders (MPD) [ 새로운 분류와 진단 기준 ] 경희의대 종양혈액내과 조 경 삼.
Hematology There are four lectures: 1.Acute leukemias (2 hours). 2.Chronic leukemias (2 hours).
Case 316 Ryan Johnson, MD; Athena Cherry, PhD; Dita Gratzinger, MD, PhD Stanford University Medical Center SH-EAHP October 24, 2013.
This syndrome consists of a group of clonal haematopoietic disorders which represent steps in the progression to the development of leukaemia. Myelodysplastic.
CP Case Conference Aplastic Anemia 1/27/12 Laura Walters.
Anemia of Chronic Disease
MYELODYSPLASTIC SYNDROMES
Acute Leukemia Kristine Krafts, M.D..
Clinical and Histologic Evaluation of Myelodysplastic Syndromes
Myelodysplastic syndrome(MDS)
EAHP Bone Marrow Workshop
Acute Myeloid Leukemia
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
MLAB Hematology Keri Brophy-Martinez
Algorithm for the classification of adult-onset primary myelodysplastic syndromes (MDS). This classification system is based on the 2008 criteria of the.
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
Chronic leukemias CML CLL MDS.
HS 4160 Critical Scientific Analysis
Acute Myeloid Leukemia
Fenaux P et al. Lancet Oncol 2009;10(3):
Chronic Myelomonocytic Leukemia: Focus on Clinical Practice
The genetic basis of myelodysplasia and its clinical relevance
Erythroid maturation.
Myelodysplastic syndromes
Lyons RM et al. J Clin Oncol 2009;27(11):
In the name of god.
Improved Outcome for Peripheral Blood Stem Cell Transplantation for Advanced Primary Myelodysplastic Syndrome  Scott R. Solomon, Bipin N. Savani, Richard.
ASH Review 2018: Update on Myelodysplastic Syndrome
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
Kantarjian HM et al. Blood 2008;112:Abstract 635.
MYELOID LEUKEMIAS Dr. B.V.Vydehi M.D PROFESSOR OF PATHOLOGY
Presentation transcript:

Diagnosis and classification of myelodysplastic ring sideroblasts 11월 28일 conference - DI 발표 |Hematologica| 2008;93(11) Diagnosis and classification of myelodysplastic ring sideroblasts 2008.11.28 DI 정유진

Objective MDS의 진단체계? (X) MDS cases들? (X) IWGM-MDS : myeloblast, promyeloblast, ring sideroblast의 형태학적 정의

골수이형증 비효율적 조혈, 혈구감소증 백혈병 (거의 대부분 AML) 전 단계 ->formerly known as "preleukemia" 30%가 AML로 변한다고 알려져 있음

Before IWGM-MDS ? FAB : 1982~ IPSS : risk assessment WHO : FAB 개정

MDS의 FAB 분류 Syndrome Peripheral Bone marrow Refractory anemia Blasts < % Blasts < 5%, ringed sideroblasts < 15% Refractory anemia with ringed sideroblasts (primary acquired sideroblastic anemia) High MCV; dimorphic red cell picture Blasts < 5%, ringed sideroblasts > 15% Refractory anemia with excess of blasts(RAEB) Blasts < 5% Blasts < 5-10% Chronic myelomonocytic leukemia(CMML) Monocyte count>1.0×109/L; granulocytes often increased; blasts < 5% Blasts < 20%; promonocytes may be increased RAEB in transformation Blasts > 5% or Auer rods present Blasts 20-30% or Auer robs present

IPSS에 의한 MDS 환자의 수명 예측 Overall Score Median Survival (yr) Low(0) Intermediate 1 (0.5 or 1.0) 2 (1.5 of 2.0) High (≥2.5) 5.7 3.5 1.2 0.4 Marrow blast : <5%, 0; 5-10%, 0.5; 11-20%, 1.5; 21-30%, 2.0 Karyotype : good [rpgmpsos (normal, -Y, 5q-, 20q-), 0 poor prognosis (abn 7, ≥3 abn), 1.0 intermediate prognosis (others), 0.5 Cytopenia : Hb <10 g/dL, ANC < 1,500/L, platelet < 100,000/L 0-1, 0; 2-3, 0.5

WHO classification and criteria for the myelodysplastic syndromes   Disease Blood findings Bone marrow findings Refractory anemia (RA) Anemia Erythroid dysplasia only No or rare blasts < 5% blasts < 15% ringed sideroblasts Refractory anemia with ringed sideroblasts (RARS) No blasts    15% ringed sideroblasts Refractory cytopenia with multilineage dysplasia (RCMD) Cytopenias (bicytopenia or pancytopenia) Dysplasia in  10% of cells in 2 or more myeloid cell lines < 5% blasts in marrow No Auer rods < 1 × 109/L monocytes Refractory cytopenia with multilineage dysplasia and ringed   sideroblasts (RCMD-RS)   15% ringed sideroblasts Refractory anemia with excess blasts-1 (RAEB-1) Cytopenias Unilineage or multilineage dysplasia 5% to 9% blasts Refractory anemia with excess blasts-2 (RAEB-2) 5% to 19% blasts 10% to 19% blasts Auer rods ± Auer rods ±  Myelodysplastic syndrome, unclassified (MDS-U) Unilineage dysplasia in granulocytes or megakaryocytes MDS associated with isolated del(5q) Normal to increased megakaryocytes with hypolobated nuclei Platelets normal or increased Isolated del(5q) WHO classification and criteria for the myelodysplastic syndromes

Blast - FAB 1) Type 1, Type 2 Type 1은 agranules type 2는 scanty granules 2) Goasguen- type3 정의 (FAB에선 promyelocytes로 분류되던 것들) ->생존률 match higher!

IWGM-MDS (International Working Group on Morphology of MDS) 1) Definition of myeloblast - granule(2)/agranule(1) 2) Promyelocytes - Normal promyelocyte: Golgi zone 3) 형태학적 구분: normal promyelocytes, blasts (granular/agranular –숫자와 관계없이), dysplastic promyleocytes

Sideroblast by IWGM-MDS Type 1 - 5개 이하 granule in cytoplasm Type 2- 5개 이상 granule, but not perinuclear Type 3(= ring sideroblast) – 5개 이상이면서 perinuclear : 핵을 둘러싸고 있거나 핵 둘레의 적어도 1/3이상 포위해야

Thank you for your attention! Blast - Granule Promyelocyte - Golgi zone Ring sideroblast – 5 granule+perinuclear Thank you for your attention!